Properdin factor D: effects on thrombin-induced platelet aggregation.
Open Access
- 1 September 1979
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 64 (3) , 721-728
- https://doi.org/10.1172/jci109515
Abstract
Factor D, when preincubated with platelet suspensions, at concentrations as low as 1.2 micrograms/ml, inhibited thrombin-induced platelet aggregation. No inhibition of collagen or arachidonic acid-induced platelet aggregation was found. Inhibition occurred, but to a lesser extent, when thrombin and factor D were added to platelets at the same time. No inhibition occurred when factor D was added after thrombin. Thrombin was able to overcome inhibition by factor D by increasing its concentration. Diisopropyl-phosphorofluoridate-inactivated factor D also inhibited thrombin-induced platelet aggregation so that enzymatic activity of factor D was not required for inhibition. Factor D absorbed with hirudin coupled to Sepharose 6B showed no decrease in inhibitory capacity. 125I-Factor D bound to platelets in a manner suggesting an equilibrium reaction similar to thrombin. At low factor D input, binding was linear, whereas at higher input, binding began to approach saturation. Binding of 125I-labeled thrombin to platelets was inhibited by factor D. Analysis of these data show that factor D does not alter the total number of thrombin molecules which bind to the platelet surface at saturation. However, the dissociation constant for thrombin is altered from 2.78 to 6.90 nM in the presence of factor D (20 micrograms/ml). Factor D is thus a competitive inhibitor of thrombin binding, although the affinity of factor D for the platelet thrombin receptor is much less than that of thrombin. These phenomena occur at physiologic concentrations of factor D. Therefore, factor D may function in vivo as an inhibitor of platelet aggregation.Keywords
This publication has 30 references indexed in Scilit:
- Mechanism of action of factor D of the alternative complement pathway.The Journal of Experimental Medicine, 1978
- The human complement system in thrombin-mediated platelet function.The Journal of Experimental Medicine, 1978
- Responses of Human Platelets to Immunologic Stimuli: Independent Roles for Complement and IgG in Zymosan ActivationThe Journal of Immunology, 1978
- Structure-function relationships in the interaction of alpha-thrombin with blood platelets.Journal of Biological Chemistry, 1977
- Mechanism of complement-mediated activation of human blood platelets in vitro: comparison of normal and paroxysmal nocturnal hemoglobinuria platelets.Journal of Clinical Investigation, 1977
- HUMAN FACTOR-D OF ALTERNATIVE COMPLEMENT PATHWAY - PURIFICATION AND CHARACTERIZATION1977
- HEREDITARY C5 DEFICIENCY IN MAN .3. STUDIES OF HEMOSTASIS AND PLATELET RESPONSES TO ZYMOSAN1977
- Equilibrium binding of thrombin to plateletsBiochemistry, 1976
- The binding of kidney-bean phytohemagglutinin by Ehrlich ascites carcinomaBiochimica et Biophysica Acta (BBA) - General Subjects, 1965
- Lactic Dehydrogenase Activity in Blood.Experimental Biology and Medicine, 1955